Massachusetts General Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
Cancer. 2020 Apr 15;126(8):1758-1765. doi: 10.1002/cncr.32680. Epub 2020 Jan 3.
Caregivers of patients undergoing hematopoietic stem cell transplantation (HCT) experience an immense caregiving burden before, during, and after HCT.
We conducted an unblinded, randomized trial of a psychosocial intervention (BMT-CARE) for caregivers of patients undergoing autologous and allogeneic HCT at Massachusetts General Hospital. Caregivers were randomly assigned to BMT-CARE or usual care. BMT-CARE was tailored to the HCT trajectory and integrated treatment-related education and self-care with cognitive-behavioral skills to promote coping. Caregivers assigned to BMT-CARE met with a trained interventionist (a psychologist or a social worker) in person, via telephone, or via videoconferencing for 6 sessions starting before HCT and continuing up to day +60 after HCT. The primary endpoint was feasibility, which was defined as at least 60% of eligible caregivers enrolling and completing 50% or more of the intervention sessions. We assesed caregiver quality of life (QOL; Caregiver Oncology Quality of Life Questionnaire), caregiving burden (Caregiver Reaction Assessment), psychological distress (Hospital Anxiety and Depression Scale), self-efficacy (Cancer Self-Efficacy Scale-Transplant), and coping (Measures of Current Status) at baseline and 30 and 60 days after HCT. We used mixed linear effect models to assess the effect of BMT-CARE on outcomes longitudinally.
We enrolled 72.5% of eligible caregivers (100 of 138), and 80% attended 50% or more of the intervention sessions. Caregivers randomized to BMT-CARE reported improved QOL (B = 6.11; 95% CI, 3.50-8.71; P < .001), reduced caregiving burden (B = -6.02; 95% CI, -8.49 to -3.55; P < .001), lower anxiety (B = -2.18; 95% CI, -3.07 to -1.28; P < .001) and depression symptoms (B = -1.23; 95% CI, -1.92 to -0.54; P < .001), and improved self-efficacy (B = 7.22; 95% CI, 2.40-12.03; P = .003) and coping skills (B = 4.83; 95% CI, 3.04-6.94; P < .001) in comparison with the usual-care group.
A brief multimodal psychosocial intervention tailored for caregivers of HCT recipients is feasible and may improve QOL, mood, coping, and self-efficacy while reducing the caregiving burden during the acute HCT period.
造血干细胞移植(HCT)患者的护理人员在 HCT 之前、期间和之后都承受着巨大的护理负担。
我们对马萨诸塞州综合医院接受自体和同种异体 HCT 的患者的护理人员进行了一项未设盲、随机的心理社会干预(BMT-CARE)试验。护理人员被随机分配到 BMT-CARE 或常规护理。BMT-CARE 根据 HCT 轨迹进行定制,并将与治疗相关的教育和自我护理与认知行为技能相结合,以促进应对。被分配到 BMT-CARE 的护理人员与经过培训的干预者(心理学家或社会工作者)进行了 6 次面对面、电话或视频会议,从 HCT 前开始,一直持续到 HCT 后第 60 天。主要终点是可行性,定义为至少 60%的合格护理人员参与并完成 50%或更多的干预课程。我们在基线和 HCT 后 30 天和 60 天评估了护理人员的生活质量(护理人员肿瘤学生活质量问卷)、护理负担(护理人员反应评估)、心理困扰(医院焦虑和抑郁量表)、自我效能(癌症自我效能量表-移植)和应对能力(当前状态测量)。我们使用混合线性效应模型来纵向评估 BMT-CARE 对结果的影响。
我们招募了 72.5%的合格护理人员(138 名中的 100 名),80%的护理人员参加了 50%或更多的干预课程。与常规护理组相比,接受 BMT-CARE 的护理人员报告生活质量得到改善(B=6.11;95%CI,3.50-8.71;P<.001),护理负担减轻(B=-6.02;95%CI,-8.49 至-3.55;P<.001),焦虑(B=-2.18;95%CI,-3.07 至-1.28;P<.001)和抑郁症状(B=-1.23;95%CI,-1.92 至-0.54;P<.001)降低,自我效能(B=7.22;95%CI,2.40-12.03;P=.003)和应对技能(B=4.83;95%CI,3.04-6.94;P<.001)提高。
针对 HCT 受者护理人员的简短多模式心理社会干预是可行的,可能会改善生活质量、情绪、应对能力和自我效能感,同时减轻 HCT 期间的护理负担。